Back to search

Article

Dexmedetomidine could ameliorate intestinal mucosal barrier injury in patients via inhibiting intestinal oxidative stress and inflammatory responses

2023-03-29

Abstract excerpt

Dexmedetomidine (Dex), a highly selective α 2 receptor agonist can inhibit excessive inflammatory reaction and. In this study, we will investigate the effects of Dex can protect against intestinal mucosal barrier injury in patients via inhibiting intestinal inflammatory responses. This is a double-blinded randomized placebo-controlled trial. Ninety-four patients with acute intestinal obstruction, aged 33-81 years...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d4a9737d-f227-5aba-a178-3fe005f28fb7
DOI
10.21203/rs.3.rs-2655476/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dexmedetomidine could ameliorate intestinal mucosal barrier injury in patients via inhibiting intestinal oxidative stress and inflammatory responsesDOI 10.21203/rs.3.rs-2655476/v1
Select a neighboring publication to make it the new centre.